MoneyWorks4Me

Bajaj Healthcare - Quaterly Results

14 Aug 2023 Evaluate
The sales declined to Rs. 1297.37 millions for the June 2023 quarter as compared to Rs. 1637.92 millions during the corresponding quarter last year.The Company to register a -51.05%  fall in the net profit for the quarter ended June 2023.The Operating Profit of the company witnessed a decrease to 219.62 millions from 251.36 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 1297.37 1637.92 -20.79 1297.37 1637.92 -20.79 6732.92 6798.89 -0.97
Other Income 2.18 6.69 -67.41 2.18 6.69 -67.41 15.98 14.44 10.66
PBIDT 219.62 251.36 -12.63 219.62 251.36 -12.63 1084.44 1199.45 -9.59
Interest 87.51 25.80 239.19 87.51 25.80 239.19 228.72 126.24 81.18
PBDT 132.11 225.56 -41.43 132.11 225.56 -41.43 855.72 1073.21 -20.27
Depreciation 63.07 40.84 54.43 63.07 40.84 54.43 273.55 176.36 55.11
PBT 69.04 184.72 -62.62 69.04 184.72 -62.62 582.17 896.85 -35.09
TAX -1.22 41.19 -102.96 -1.22 41.19 -102.96 151.92 182.98 -16.97
Deferred Tax -1.22 -1.41 -13.48 -1.22 -1.41 -13.48 -11.66 -6.14 89.90
PAT 70.26 143.53 -51.05 70.26 143.53 -51.05 430.25 713.87 -39.73
Equity 137.99 137.99 0.00 137.99 137.99 0.00 137.99 137.99 0.00
PBIDTM(%) 16.93 15.35 10.31 16.93 15.35 10.31 16.11 17.64 -8.70
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..